A possible role of GLP-1 in the pathophysiology of early dumping syndrome

Digestive Diseases and Sciences

Volumn 50, Issue 12, 2005, Pages 2263-2267

  Yamamoto, Hiroshi ^a   Mori, Tsuyoshi ^a   Tsuchihashi, Hiroshi ^a   Akabori, Hiroya ^a   Naito, Hiroyuki ^a   Tani, Tohru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Dumping syndrome; GLP 1; Insulin; Norepinephrine; Sympathetic

Indexed keywords

ADRENALIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTRECTOMY; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYMPATHETIC TONE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CATECHOLAMINES; DUMPING SYNDROME; FEMALE; GASTRECTOMY; GLUCAGON-LIKE PEPTIDE 1; HEMODYNAMIC PROCESSES; HUMANS; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 30844455164     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3046-2     Document Type: Article

References (29)

1. Carvajal SH, Mulvihill SJ: Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin North Am 23:261-279, 1994
2. Ralphs DN, Thomson JP, Haynes S, Lawson-Smith C, Hobsley M, Le Quesne LP: The relationship between the rate of gastric emptying and the dumping syndrome. Br J Surg 65:637-641, 1978
3. Bloom SR, Royston CM, Thomson JP: Enteroglucagon release in the dumping syndrome. Lancet 14:789-791, 1972
4. Sagor GR, Bryant MG, Ghatei MA, Kirk RM, Bloom SR: Release of vasoactive intestinal peptide in the dumping syndrome. Br Med J 14:507-510, 1981
5. Blackburn AM, Christofides ND, Ghatei MA, Sarson DL, Ebeid FH, Ralphs DN, Bloom SR: Elevation of plasma neurotensin in the dumping syndrome. Clin Sci (Lond) 59:237-243, 1980
6. Johnson LP, Sloop RD, Jesseph JE: Treatment of "dumping" with serotonin antagonists: preliminary report. JAMA 12:493-494, 1962
7. Woodward ER, Neustein CL: The late postprandial dumping syndrome: Major Probl Clin Surg 20:28-33, 1976
8. Toft-Nielsen M, Madsbad S, Holst JJ: Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycemia. Diabetologia 41:1180-1186, 1998
9. Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304, 1987
10. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Drucker DJ, Elmquist JK: Central administration of glucagon-like peptide-1 receptor agonist increases blood pressure and heart rate, activates autonomic regulatory neurons. J Clin Invest 110:43-52, 2002
11. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites: J Neurosci 1:2939-2946, 2003
12. Gebhard B, Holst JJ, Biegelmayer C, Miholic J: Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 46:1915-1923, 2001
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 10:1183-1197, 1997
14. Sigstad H: A clinical diagnostic index in the diagnosis of the dumping syndrome. Acta Med Scand 188:479-486, 1986
15. Barragan JM, Eng J, Rodriguez R, Blazquez E: Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 277:784-791, 1999
16. Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ: Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am. J Physiol 272:726-730, 1997
17. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72, 1996
18. Larsen PJ, Tang-Christensen M, Jessop DS: Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology. 138:4445-4455, 1997
19. Mojsov S, Weir GC, Habener JF: Insulinotropic: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619, 1987
20. Hasler WL: Dumping syndrome. Curr Treat Options Gastroenterol 5:139-145, 2002
21. Shemerdiak WP, Abramson EC, Schlesinger PK, Werner PL: Catecholamines in the early dumping syndrome. Clin Chem 28:722-723, 1982
22. Elbrond B, Jakobsen G, Larsen S, Agerso H, Jensen LB, Rolan P, Sturis J, Hatorp V, Zdravkovic M: Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects. Diabetes Care25:1398-1404, 2002
23. Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR: NN2211-1310 International Study Group. Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial. Diabetes Care. 27:1335-1342, 2004
24. Welle S, Lilavivathana U, Campbell RG: Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. Metabolism. 29:806-809, 1980
25. Levin BE: Glucose increases rat plasma norepinephrine levels by direct action on the brain. Am J Physiol 261:1351-1357, 1991
26. Geer RJ, Richards WO, O'Dorisio TM, Woltering EO, Williams S, Rice D, Abumrad NN: Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 212:678-687, 1990
27. Hasler WL, Soudah HC, Owyang C: Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther 277:1359-1365, 1996
28. Stark A, Mentlein R: Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells. Regul Pept 15:97-102, 2002
29. Velasquez-Mieyer PA, Umpierrez GE, Lustig RH, Cashion AK, Cowan PA, Christensen M, Spencer KA, Burghen GA: Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults. Int J Obes Relat Metab Disor. 28:330-333, 2004